Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 22, 2022 06:44PM
|
Re: Q1- March 31, 2022 on SEDAR
|
4
|
Resverlogix Corp.
|
May 16, 2022 01:16PM
|
Re: Q4 2019 Events
|
4
|
Resverlogix Corp.
|
Oct 01, 2019 04:37PM
|
Re: Qatar Research overview of apabetalone
|
3
|
Resverlogix Corp.
|
Apr 23, 2024 09:40PM
|
Re: Question
|
6
|
Resverlogix Corp.
|
Feb 25, 2021 09:52AM
|
Re: Question for posters
|
4
|
Resverlogix Corp.
|
Dec 12, 2021 11:54AM
|
Re: Question for the board re: partnership deal
|
3
|
Resverlogix Corp.
|
Nov 06, 2020 12:49PM
|
Re: Question on Rosuvastatin versus Astorvastatin
|
4
|
Resverlogix Corp.
|
Sep 06, 2019 09:33AM
|
Re: Question on Rosuvastatin versus Astorvastatin
|
5
|
Resverlogix Corp.
|
Sep 06, 2019 09:53AM
|
Re: Question on Rosuvastatin versus Astorvastatin
|
3
|
Resverlogix Corp.
|
Sep 06, 2019 12:27PM
|
Re: Question re BOD votes
|
10
|
Resverlogix Corp.
|
Jun 25, 2022 12:29PM
|
Re: Questions about Breakthrough Therapy
|
5
|
Resverlogix Corp.
|
Feb 04, 2020 10:28AM
|
Re: Random thoughts in the vacuum of information
|
6
|
Resverlogix Corp.
|
Jul 01, 2024 08:59AM
|
Re: Rant time...
|
11
|
Resverlogix Corp.
|
Feb 05, 2021 11:02AM
|
Re: Rant time...
|
5
|
Resverlogix Corp.
|
Feb 05, 2021 12:08PM
|
Re: Received a response....Third Eye Loan Balance
|
3
|
Resverlogix Corp.
|
Jul 14, 2019 10:42AM
|
Re: Recent publications:
|
6
|
Resverlogix Corp.
|
Sep 27, 2023 02:13PM
|
Re: Recent publications:
|
4
|
Resverlogix Corp.
|
Sep 27, 2023 04:16PM
|
Re: Restricted Share Units - approx. 5 million
|
3
|
Resverlogix Corp.
|
Jul 07, 2020 12:12PM
|
Re: Restricted Share Units - approx. 5 million
|
1
|
Resverlogix Corp.
|
Jul 07, 2020 01:53PM
|